Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver disease

Autor: Subashini Chandrapalan, Jessica K Dyson, Laura Haigh, William Taylor, Stuart McPherson, Mohammed Hussien, Sophia Oxenburgh, Quentin M. Anstee, Naw April Phaw, Kate Hallsworth, Timothy Hardy, Steven Masson, David Beaton, Sarah Galbraith, Dina Mansour, Shi Looi, Louise Macdougall, Phey Shen Lee, Alaa Ebraheem, Laura J Neilson

Publikováno v: Frontline Gastroenterology

BackgroundNon-alcoholic fatty liver disease (NAFLD) is common and is associated with liver-related and cardiovascular-related morbidity. Our aims were: (1) to review the current management of patients with NAFLD attending hospital clinics in North Ea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06a6e3ba861884a040c720bac2cfe7a4
http://europepmc.org/articles/PMC8640379

Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF therapy (IMSAT) therapeutic drug monitoring study.

Autor: Chanchlani, Neil¹ (AUTHOR) neilchanchlani@nhs.net, Lin, Simeng¹ (AUTHOR), Auth, Marcus K.² (AUTHOR), Lee, Chai Leng² (AUTHOR), Robbins, Helena³ (AUTHOR), Looi, Shi³ (AUTHOR), Murugesan, Senthil V.⁴ (AUTHOR), Riley, Tom⁴ (AUTHOR), Preston, Cathryn⁵ (AUTHOR), Stephenson, Sophie⁵ (AUTHOR), Cardozo, Wendy⁵ (AUTHOR), Sonwalkar, Sunil A.⁶ (AUTHOR), Allah‐Ditta, Mohammed⁶ (AUTHOR), Mansfield, Lynne⁶ (AUTHOR), Durai, Dharmaraj⁷ (AUTHOR), Baker, Mark⁷ (AUTHOR), London, Ian⁸ (AUTHOR), London, Emily⁸ (AUTHOR), Gupta, Sanjay⁹ (AUTHOR), Di Mambro, Alex¹⁰ (AUTHOR)

Publikováno v: Alimentary Pharmacology & Therapeutics. Oct2022, Vol. 56 Issue 8, p1250-1263. 14p. 1 Diagram, 2 Charts, 4 Graphs.